Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
More effective rotavirus vaccines are essential for preventing extensive diarrheal morbidity and mortality in children under five years of age in low-resource regions. Nonreplicating rotavirus vaccines (NRRV) administered parenterally provide an alternate vaccination method to the current licensed o...
Saved in:
Main Authors: | Kyle Lakatos (Author), David McAdams (Author), Jessica A. White (Author), Dexiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development
by: Daniel E. Velasquez, et al.
Published: (2019) -
Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus
by: Khadijeh Nasiri, et al.
Published: (2016) -
A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response
by: Ming Xia, et al.
Published: (2022) -
Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in <i>Nicotiana benthamiana</i>
by: Maria Malm, et al.
Published: (2019) -
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
by: Sita Awasthi, et al.
Published: (2017)